DOI QR코드

DOI QR Code

Is the Combination of Neutrophil to Lymphocyte and Platelet to Lymphocyte Ratios a Useful Predictor of Treatment Response and Prognosis in Patients with Non-Small Cell Lung Cancer?

  • Tanoglu, Alpaslan (Department of Gastroenterology, GATA Haydarpasa Training Hospital) ;
  • Yiyit, Nurettin (Department of Thoracic Surgery, GATA Haydarpasa Training Hospital) ;
  • Berber, Ufuk (Department of Pathology, GATA Haydarpasa Training Hospital) ;
  • Karagoz, Ergenekon (Department of Infectious Diseases and Clinical Microbiology, GATA Haydarpasa Training Hospital)
  • 발행 : 2014.05.30

초록

키워드

참고문헌

  1. Smith RA, Ghaneh P, Sutton R, et al (2008).Prognosis of resected ampullary adenocarcinoma by preoperative serum CA19-9 levels and platelet-lymphocyte ratio. J Gastrointest Surg, 12, 1422-8. https://doi.org/10.1007/s11605-008-0554-3
  2. Stotz M, Gerger A, Eisner F, et al (2013). Increased neutrophillymphocyte ratio is a poor prognostic factor in patients with primary operable and inoperable pancreatic cancer. Br J Cancer, 109, 416-21. https://doi.org/10.1038/bjc.2013.332
  3. Tanoglu A, Karagoz E, Yiyit N, Berber U (2014). Is combination of neutrophil to lymphocyte ratio and platelet lymphocyte ratio a useful predictor of postoperative survival in patients with esophageal squamous cell carcinoma? Onco Targets Ther, 7, 433-4.
  4. Tanoglu A, Karagoz E (2014). Predictive role of neutrophil to lymphocyte ratio in patients with advanced hepatocelluler carcinoma receiving sorafenib. Asian Pac J Cancer Prev, 15, 1063. https://doi.org/10.7314/APJCP.2014.15.2.1063
  5. Unal D1, Eroglu C, Kurtul N, Oguz A, Tasdemir A. (2013). Are neutrophil/lymphocyte and platelet/lymphocyte rates in patients with non small cell lung cancer associated with treatment response and prognosis? Asian Pac J Cancer Prev, 14, 5237-42. https://doi.org/10.7314/APJCP.2013.14.9.5237
  6. Wang D, Yang JX, Cao DY, et al (2013). Preoperative neutrophillymphocyte and platelet-lymphocyte ratios as independent predictors of cervical stromal involvement in surgically treated endometrioid adenocarcinoma. OncoTargets Ther, 6, 211-6
  7. Zheng YB, Zhao W, Liu B, et al (2013). The blood neutrophil-tolymphocyte ratio predicts survival in patients with advanced hepatocellular carcinoma receiving sorafenib. Asian Pac J Cancer Prev, 14, 5527-31. https://doi.org/10.7314/APJCP.2013.14.9.5527